Global Aminoglycosides Antibiotics Drug Market Research Report 2023
Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
According to QYResearch’s new survey, global Aminoglycosides Antibiotics Drug market is projected to reach US$ 1102.5 million in 2029, increasing from US$ 1056 million in 2022, with the CAGR of 0.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aminoglycosides Antibiotics Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Aminoglycosides Antibiotics Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Aminoglycosides Antibiotics Drug market is projected to reach US$ 1102.5 million in 2029, increasing from US$ 1056 million in 2022, with the CAGR of 0.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aminoglycosides Antibiotics Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Aminoglycosides Antibiotics Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Jemicare
- Teva
- Novartis
- Fangyuan-pharma
- Aike Pharmaceutical
- Cipla
- Pfizer
- Fresenius Kabi
- Sun Pharma
- Hikma
- Lannett Company
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Etimicin
- Others
- Hospital
- Clinic
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Aminoglycosides Antibiotics Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Aminoglycosides Antibiotics Drug Market Perspective (2018-2029)
2.2 Aminoglycosides Antibiotics Drug Growth Trends by Region
2.2.1 Global Aminoglycosides Antibiotics Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Aminoglycosides Antibiotics Drug Historic Market Size by Region (2018-2023)
2.2.3 Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2024-2029)
2.3 Aminoglycosides Antibiotics Drug Market Dynamics
2.3.1 Aminoglycosides Antibiotics Drug Industry Trends
2.3.2 Aminoglycosides Antibiotics Drug Market Drivers
2.3.3 Aminoglycosides Antibiotics Drug Market Challenges
2.3.4 Aminoglycosides Antibiotics Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Aminoglycosides Antibiotics Drug Players by Revenue
3.1.1 Global Top Aminoglycosides Antibiotics Drug Players by Revenue (2018-2023)
3.1.2 Global Aminoglycosides Antibiotics Drug Revenue Market Share by Players (2018-2023)
3.2 Global Aminoglycosides Antibiotics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aminoglycosides Antibiotics Drug Revenue
3.4 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio
3.4.1 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aminoglycosides Antibiotics Drug Revenue in 2022
3.5 Aminoglycosides Antibiotics Drug Key Players Head office and Area Served
3.6 Key Players Aminoglycosides Antibiotics Drug Product Solution and Service
3.7 Date of Enter into Aminoglycosides Antibiotics Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AMINOGLYCOSIDES ANTIBIOTICS DRUG BREAKDOWN DATA BY TYPE
4.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Type (2018-2023)
4.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2024-2029)
5 AMINOGLYCOSIDES ANTIBIOTICS DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Application (2018-2023)
5.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Aminoglycosides Antibiotics Drug Market Size (2018-2029)
6.2 North America Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
6.4 North America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Aminoglycosides Antibiotics Drug Market Size (2018-2029)
7.2 Europe Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
7.4 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size (2018-2029)
8.2 Asia-Pacific Aminoglycosides Antibiotics Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Aminoglycosides Antibiotics Drug Market Size (2018-2029)
9.2 Latin America Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
9.4 Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size (2018-2029)
10.2 Middle East & Africa Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Jemicare
11.1.1 Jemicare Company Detail
11.1.2 Jemicare Business Overview
11.1.3 Jemicare Aminoglycosides Antibiotics Drug Introduction
11.1.4 Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.1.5 Jemicare Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Aminoglycosides Antibiotics Drug Introduction
11.2.4 Teva Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Aminoglycosides Antibiotics Drug Introduction
11.3.4 Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Fangyuan-pharma
11.4.1 Fangyuan-pharma Company Detail
11.4.2 Fangyuan-pharma Business Overview
11.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Drug Introduction
11.4.4 Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.4.5 Fangyuan-pharma Recent Development
11.5 Aike Pharmaceutical
11.5.1 Aike Pharmaceutical Company Detail
11.5.2 Aike Pharmaceutical Business Overview
11.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Introduction
11.5.4 Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.5.5 Aike Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Aminoglycosides Antibiotics Drug Introduction
11.6.4 Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.6.5 Cipla Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Aminoglycosides Antibiotics Drug Introduction
11.7.4 Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Detail
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Aminoglycosides Antibiotics Drug Introduction
11.8.4 Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.8.5 Fresenius Kabi Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Aminoglycosides Antibiotics Drug Introduction
11.9.4 Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.9.5 Sun Pharma Recent Development
11.10 Hikma
11.10.1 Hikma Company Detail
11.10.2 Hikma Business Overview
11.10.3 Hikma Aminoglycosides Antibiotics Drug Introduction
11.10.4 Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.10.5 Hikma Recent Development
11.11 Lannett Company
11.11.1 Lannett Company Company Detail
11.11.2 Lannett Company Business Overview
11.11.3 Lannett Company Aminoglycosides Antibiotics Drug Introduction
11.11.4 Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.11.5 Lannett Company Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Etimicin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Aminoglycosides Antibiotics Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Aminoglycosides Antibiotics Drug Market Perspective (2018-2029)
2.2 Aminoglycosides Antibiotics Drug Growth Trends by Region
2.2.1 Global Aminoglycosides Antibiotics Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Aminoglycosides Antibiotics Drug Historic Market Size by Region (2018-2023)
2.2.3 Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2024-2029)
2.3 Aminoglycosides Antibiotics Drug Market Dynamics
2.3.1 Aminoglycosides Antibiotics Drug Industry Trends
2.3.2 Aminoglycosides Antibiotics Drug Market Drivers
2.3.3 Aminoglycosides Antibiotics Drug Market Challenges
2.3.4 Aminoglycosides Antibiotics Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Aminoglycosides Antibiotics Drug Players by Revenue
3.1.1 Global Top Aminoglycosides Antibiotics Drug Players by Revenue (2018-2023)
3.1.2 Global Aminoglycosides Antibiotics Drug Revenue Market Share by Players (2018-2023)
3.2 Global Aminoglycosides Antibiotics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aminoglycosides Antibiotics Drug Revenue
3.4 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio
3.4.1 Global Aminoglycosides Antibiotics Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aminoglycosides Antibiotics Drug Revenue in 2022
3.5 Aminoglycosides Antibiotics Drug Key Players Head office and Area Served
3.6 Key Players Aminoglycosides Antibiotics Drug Product Solution and Service
3.7 Date of Enter into Aminoglycosides Antibiotics Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AMINOGLYCOSIDES ANTIBIOTICS DRUG BREAKDOWN DATA BY TYPE
4.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Type (2018-2023)
4.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2024-2029)
5 AMINOGLYCOSIDES ANTIBIOTICS DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Aminoglycosides Antibiotics Drug Historic Market Size by Application (2018-2023)
5.2 Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Aminoglycosides Antibiotics Drug Market Size (2018-2029)
6.2 North America Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
6.4 North America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Aminoglycosides Antibiotics Drug Market Size (2018-2029)
7.2 Europe Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
7.4 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size (2018-2029)
8.2 Asia-Pacific Aminoglycosides Antibiotics Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Aminoglycosides Antibiotics Drug Market Size (2018-2029)
9.2 Latin America Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
9.4 Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size (2018-2029)
10.2 Middle East & Africa Aminoglycosides Antibiotics Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Jemicare
11.1.1 Jemicare Company Detail
11.1.2 Jemicare Business Overview
11.1.3 Jemicare Aminoglycosides Antibiotics Drug Introduction
11.1.4 Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.1.5 Jemicare Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Aminoglycosides Antibiotics Drug Introduction
11.2.4 Teva Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Aminoglycosides Antibiotics Drug Introduction
11.3.4 Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Fangyuan-pharma
11.4.1 Fangyuan-pharma Company Detail
11.4.2 Fangyuan-pharma Business Overview
11.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Drug Introduction
11.4.4 Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.4.5 Fangyuan-pharma Recent Development
11.5 Aike Pharmaceutical
11.5.1 Aike Pharmaceutical Company Detail
11.5.2 Aike Pharmaceutical Business Overview
11.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Introduction
11.5.4 Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.5.5 Aike Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Aminoglycosides Antibiotics Drug Introduction
11.6.4 Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.6.5 Cipla Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Aminoglycosides Antibiotics Drug Introduction
11.7.4 Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Detail
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Aminoglycosides Antibiotics Drug Introduction
11.8.4 Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.8.5 Fresenius Kabi Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Aminoglycosides Antibiotics Drug Introduction
11.9.4 Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.9.5 Sun Pharma Recent Development
11.10 Hikma
11.10.1 Hikma Company Detail
11.10.2 Hikma Business Overview
11.10.3 Hikma Aminoglycosides Antibiotics Drug Introduction
11.10.4 Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.10.5 Hikma Recent Development
11.11 Lannett Company
11.11.1 Lannett Company Company Detail
11.11.2 Lannett Company Business Overview
11.11.3 Lannett Company Aminoglycosides Antibiotics Drug Introduction
11.11.4 Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023)
11.11.5 Lannett Company Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Neomycin
Table 3. Key Players of Tobramycin
Table 4. Key Players of Gentamicin
Table 5. Key Players of Amikacin
Table 6. Key Players of Etimicin
Table 7. Key Players of Others
Table 8. Global Aminoglycosides Antibiotics Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Aminoglycosides Antibiotics Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Aminoglycosides Antibiotics Drug Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Aminoglycosides Antibiotics Drug Market Share by Region (2018-2023)
Table 12. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Aminoglycosides Antibiotics Drug Market Share by Region (2024-2029)
Table 14. Aminoglycosides Antibiotics Drug Market Trends
Table 15. Aminoglycosides Antibiotics Drug Market Drivers
Table 16. Aminoglycosides Antibiotics Drug Market Challenges
Table 17. Aminoglycosides Antibiotics Drug Market Restraints
Table 18. Global Aminoglycosides Antibiotics Drug Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Aminoglycosides Antibiotics Drug Market Share by Players (2018-2023)
Table 20. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2022)
Table 21. Ranking of Global Top Aminoglycosides Antibiotics Drug Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Aminoglycosides Antibiotics Drug Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Aminoglycosides Antibiotics Drug Product Solution and Service
Table 25. Date of Enter into Aminoglycosides Antibiotics Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Aminoglycosides Antibiotics Drug Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2018-2023)
Table 29. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Aminoglycosides Antibiotics Drug Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2018-2023)
Table 33. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2024-2029)
Table 35. North America Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 50. Jemicare Company Detail
Table 51. Jemicare Business Overview
Table 52. Jemicare Aminoglycosides Antibiotics Drug Product
Table 53. Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 54. Jemicare Recent Development
Table 55. Teva Company Detail
Table 56. Teva Business Overview
Table 57. Teva Aminoglycosides Antibiotics Drug Product
Table 58. Teva Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 59. Teva Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Aminoglycosides Antibiotics Drug Product
Table 63. Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Fangyuan-pharma Company Detail
Table 66. Fangyuan-pharma Business Overview
Table 67. Fangyuan-pharma Aminoglycosides Antibiotics Drug Product
Table 68. Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 69. Fangyuan-pharma Recent Development
Table 70. Aike Pharmaceutical Company Detail
Table 71. Aike Pharmaceutical Business Overview
Table 72. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product
Table 73. Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 74. Aike Pharmaceutical Recent Development
Table 75. Cipla Company Detail
Table 76. Cipla Business Overview
Table 77. Cipla Aminoglycosides Antibiotics Drug Product
Table 78. Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 79. Cipla Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer Aminoglycosides Antibiotics Drug Product
Table 83. Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Fresenius Kabi Company Detail
Table 86. Fresenius Kabi Business Overview
Table 87. Fresenius Kabi Aminoglycosides Antibiotics Drug Product
Table 88. Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 89. Fresenius Kabi Recent Development
Table 90. Sun Pharma Company Detail
Table 91. Sun Pharma Business Overview
Table 92. Sun Pharma Aminoglycosides Antibiotics Drug Product
Table 93. Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 94. Sun Pharma Recent Development
Table 95. Hikma Company Detail
Table 96. Hikma Business Overview
Table 97. Hikma Aminoglycosides Antibiotics Drug Product
Table 98. Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 99. Hikma Recent Development
Table 100. Lannett Company Company Detail
Table 101. Lannett Company Business Overview
Table 102. Lannett Company Aminoglycosides Antibiotics Drug Product
Table 103. Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 104. Lannett Company Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 1. Global Aminoglycosides Antibiotics Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Neomycin
Table 3. Key Players of Tobramycin
Table 4. Key Players of Gentamicin
Table 5. Key Players of Amikacin
Table 6. Key Players of Etimicin
Table 7. Key Players of Others
Table 8. Global Aminoglycosides Antibiotics Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Aminoglycosides Antibiotics Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Aminoglycosides Antibiotics Drug Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Aminoglycosides Antibiotics Drug Market Share by Region (2018-2023)
Table 12. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Aminoglycosides Antibiotics Drug Market Share by Region (2024-2029)
Table 14. Aminoglycosides Antibiotics Drug Market Trends
Table 15. Aminoglycosides Antibiotics Drug Market Drivers
Table 16. Aminoglycosides Antibiotics Drug Market Challenges
Table 17. Aminoglycosides Antibiotics Drug Market Restraints
Table 18. Global Aminoglycosides Antibiotics Drug Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Aminoglycosides Antibiotics Drug Market Share by Players (2018-2023)
Table 20. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2022)
Table 21. Ranking of Global Top Aminoglycosides Antibiotics Drug Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Aminoglycosides Antibiotics Drug Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Aminoglycosides Antibiotics Drug Product Solution and Service
Table 25. Date of Enter into Aminoglycosides Antibiotics Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Aminoglycosides Antibiotics Drug Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2018-2023)
Table 29. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Aminoglycosides Antibiotics Drug Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2018-2023)
Table 33. Global Aminoglycosides Antibiotics Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Application (2024-2029)
Table 35. North America Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2024-2029) & (US$ Million)
Table 50. Jemicare Company Detail
Table 51. Jemicare Business Overview
Table 52. Jemicare Aminoglycosides Antibiotics Drug Product
Table 53. Jemicare Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 54. Jemicare Recent Development
Table 55. Teva Company Detail
Table 56. Teva Business Overview
Table 57. Teva Aminoglycosides Antibiotics Drug Product
Table 58. Teva Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 59. Teva Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Aminoglycosides Antibiotics Drug Product
Table 63. Novartis Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Fangyuan-pharma Company Detail
Table 66. Fangyuan-pharma Business Overview
Table 67. Fangyuan-pharma Aminoglycosides Antibiotics Drug Product
Table 68. Fangyuan-pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 69. Fangyuan-pharma Recent Development
Table 70. Aike Pharmaceutical Company Detail
Table 71. Aike Pharmaceutical Business Overview
Table 72. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product
Table 73. Aike Pharmaceutical Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 74. Aike Pharmaceutical Recent Development
Table 75. Cipla Company Detail
Table 76. Cipla Business Overview
Table 77. Cipla Aminoglycosides Antibiotics Drug Product
Table 78. Cipla Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 79. Cipla Recent Development
Table 80. Pfizer Company Detail
Table 81. Pfizer Business Overview
Table 82. Pfizer Aminoglycosides Antibiotics Drug Product
Table 83. Pfizer Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Fresenius Kabi Company Detail
Table 86. Fresenius Kabi Business Overview
Table 87. Fresenius Kabi Aminoglycosides Antibiotics Drug Product
Table 88. Fresenius Kabi Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 89. Fresenius Kabi Recent Development
Table 90. Sun Pharma Company Detail
Table 91. Sun Pharma Business Overview
Table 92. Sun Pharma Aminoglycosides Antibiotics Drug Product
Table 93. Sun Pharma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 94. Sun Pharma Recent Development
Table 95. Hikma Company Detail
Table 96. Hikma Business Overview
Table 97. Hikma Aminoglycosides Antibiotics Drug Product
Table 98. Hikma Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 99. Hikma Recent Development
Table 100. Lannett Company Company Detail
Table 101. Lannett Company Business Overview
Table 102. Lannett Company Aminoglycosides Antibiotics Drug Product
Table 103. Lannett Company Revenue in Aminoglycosides Antibiotics Drug Business (2018-2023) & (US$ Million)
Table 104. Lannett Company Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Aminoglycosides Antibiotics Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Aminoglycosides Antibiotics Drug Market Share by Type: 2022 VS 2029
Figure 3. Neomycin Features
Figure 4. Tobramycin Features
Figure 5. Gentamicin Features
Figure 6. Amikacin Features
Figure 7. Etimicin Features
Figure 8. Others Features
Figure 9. Global Aminoglycosides Antibiotics Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Aminoglycosides Antibiotics Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Aminoglycosides Antibiotics Drug Report Years Considered
Figure 15. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Aminoglycosides Antibiotics Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Aminoglycosides Antibiotics Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Aminoglycosides Antibiotics Drug Market Share by Players in 2022
Figure 19. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Aminoglycosides Antibiotics Drug Revenue in 2022
Figure 21. North America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 23. United States Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 27. Germany Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share by Region (2018-2029)
Figure 35. China Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 43. Mexico Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 47. Turkey Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Jemicare Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 50. Teva Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 52. Fangyuan-pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 53. Aike Pharmaceutical Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 54. Cipla Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 55. Pfizer Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 56. Fresenius Kabi Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 57. Sun Pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 58. Hikma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 59. Lannett Company Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Figure 1. Global Aminoglycosides Antibiotics Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Aminoglycosides Antibiotics Drug Market Share by Type: 2022 VS 2029
Figure 3. Neomycin Features
Figure 4. Tobramycin Features
Figure 5. Gentamicin Features
Figure 6. Amikacin Features
Figure 7. Etimicin Features
Figure 8. Others Features
Figure 9. Global Aminoglycosides Antibiotics Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Aminoglycosides Antibiotics Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Aminoglycosides Antibiotics Drug Report Years Considered
Figure 15. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Aminoglycosides Antibiotics Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Aminoglycosides Antibiotics Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Aminoglycosides Antibiotics Drug Market Share by Players in 2022
Figure 19. Global Top Aminoglycosides Antibiotics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Aminoglycosides Antibiotics Drug Revenue in 2022
Figure 21. North America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 23. United States Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 27. Germany Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share by Region (2018-2029)
Figure 35. China Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 43. Mexico Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2018-2029)
Figure 47. Turkey Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Aminoglycosides Antibiotics Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Jemicare Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 50. Teva Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 52. Fangyuan-pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 53. Aike Pharmaceutical Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 54. Cipla Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 55. Pfizer Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 56. Fresenius Kabi Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 57. Sun Pharma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 58. Hikma Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 59. Lannett Company Revenue Growth Rate in Aminoglycosides Antibiotics Drug Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
